Bringing together breathtakingly ambitious scientists with world-class engineers, from across the spectrum and not just the life sciences, Tachmed will deliver new products that are transformative and disruptive.
Paul Christie, CEO of Tachmed, explained the company’s vision in an interview with Labiotech. To read the full interview visit:
https://www.labiotech.eu/trends-news/tachmed-healthcare-more-accessible/